SPONSOR
University of Birmingham
Total Trials
6
Recruiting
6
Phases
Phase 1, Phase 2, Phase 4, Phase 2, Phase 2, Phase 3
Conditions studied: Relapsed NeuroblastomaGliomaAtrial FibrillationAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic SyndromesNon Hodgkin LymphomaHodgkin LymphomaMultiple Myeloma
University of Birmingham is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Relapsed Neuroblastoma, Glioma, Atrial Fibrillation, Acute Myeloid Leukemia.
The trial portfolio spans Phase 1, Phase 2, Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Birmingham
How many clinical trials has University of Birmingham sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by University of Birmingham, of which 6 are actively recruiting participants. These trials cover conditions including Relapsed Neuroblastoma, Glioma, Atrial Fibrillation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Birmingham research focus on?
University of Birmingham clinical trials span Relapsed Neuroblastoma, Glioma, Atrial Fibrillation, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Birmingham clinical trial?
To participate in a University of Birmingham trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Birmingham trials with current recruitment status updated daily.
Clinical Trials by University of Birmingham
NCT07334301 Phase 1, Phase 2
Recruiting
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Relapsed Neuroblastoma
NCT04274283
Recruiting
Tessa Jowell BRAIN MATRIX - Platform Study
Glioma
NCT04700826 Phase 4
Recruiting
Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation
Atrial Fibrillation
NCT04888741 Phase 2
Recruiting
Methods of T Cell Depletion Trial (MoTD)
Acute Myeloid Leukemia
NCT06774001
Recruiting
A Global Prospective Cohort Study on Outcomes of Appendicectomy for Appendicitis
Appendicitis
NCT05991388 Phase 2, Phase 3
Recruiting
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
B-cell Non Hodgkin Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology